Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Operating Activities
Net loss	$ (137,314)	$ (131,827)	$ (101,696)
Net loss from discontinued operations	(5,796)	(1,406)	865
Net loss from continuing operations	(131,518)	(130,421)	(102,561)
Adjustments to reconcile net loss to cash provided by operatings activities:
Depreciation and amortization of premises and equipment	3,321	3,649	3,700
Provision for loan losses	67,362	132,755	61,509
Deferred income taxes	641	1,307	9,854
Deferred loan fees and costs, net	(760)	(775)	(1,599)
Premium amortization and discount accretion of investment securities, net	3,869	(3,814)	(1,689)
Net gain on sale of investment securities	(7,298)	(10,647)	(989)
Other-than-temporary impairment charge			4,985
Amortization of core deposit premiums	896	795	794
Net accretion of purchase accounting adjustments	(1,731)
Stock compensation expense	23	50	405
Increase in cash surrender value of bank-owned life insurance	(1,115)	(1,085)	(1,187)
Loans held for sale:
Origination of loans held for sale		(118,251)	(180,362)
Net proceeds from sale of loans held for sale	17,966	128,403	181,774
Net loss/(gain) on sale of loans held for sale	1,241	(2,120)	(1,580)
Mortgage servicing rights capitalized		(1,340)	(1,642)
Mortgage servicing rights amortization and impairment	117	3,748	829
Net gain on sale of premises and equipment	(15)
Gain on retirement of subordinated debt	(1,625)
Goodwill impairment			52,395
Net loss on sales and write-downs of other real estate owned	44,249	9,939	1,771
Changes in assets and liabilities:
Decrease/(increase) in accrued interest receivable and other assets	20,781	5,163	(16,453)
Increase/(decrease) in accrued interest payable and other liabilities	5,443	2,279	2,447
Net cash provided by/(used in) operating activities of continuing operations	21,847	19,635	12,401
Net effect of discontinued operations	31,885	12,554	(23,069)
Net cash provided by/(used in) operating activities	53,732	32,189	(10,668)
Investing Activities
Proceeds from sales	290,491	214,181	40,789
Proceeds from maturities, calls and principal repayments	77,486	100,694	85,959
Purchases	(302,830)	(291,341)	(158,398)
Held-to-maturity securities:
Proceeds from maturities, calls and principal repayments		6,184	20,367
Purchases			(78,548)
Net decrease/(increase) in loans held for investment	179,854	91,230	(55,591)
Proceeds from sales of loans held for investment	25,503	33,505
Proceeds from sales of other real estate owned	57,634	10,981	4,954
Improvements to other real estate owned		(363)	(439)
Proceeds from settlement of bank-owned life insurance			205
Purchases of premises and equipment	(2,696)	(750)	(972)
Proceeds from sales of premises and equipment	334
Purchases of Small Business Investment Company ("SBIC") investments			(100)
Proceeds from sale of mortgage servicing rights	2,242
Net cash received in acquisition	99,126
Net cash provided by/(used in) investing activities of continuing operations	427,144	164,321	(141,774)
Net effect of discontinued operations	354	(232)	(68)
Net cash provided by/(used in) investing activities	427,498	164,089	(141,842)
Financing Activities
Net (decrease)/increase in deposits	(286,318)	(25,738)	207,381
Decrease in retail repurchase agreements	(790)	(3,964)	(4,553)
Decrease in Federal Home Loan Bank advances	(86,115)	(23,036)	(72,813)
Decrease in Federal funds purchased		(10,000)	(27,000)
Repayment of subordinated debt	(875)
Proceeds from issuance of Series A preferred stock and common stock warrant			51,500
Repurchase and retirement of preferred stock	(3,125)
Issuance of common stock, net of expense	289,571
Cash dividends paid on common stock			(1,714)
Cash dividends paid on preferred stock	(756)
Cash dividends paid on Series A preferred stock		(644)	(1,946)
Net cash provided by/(used in) financing activities of continuing operations	(88,408)	(63,382)	150,855
Net effect of discontinued operations
Net cash provided by/(used in) financing activities	(88,408)	(63,382)	150,855
Net Increase in Cash and Cash Equivalents	392,822	132,896	(1,655)
Cash and Cash Equivalents at Beginning of Period	160,594	27,698	29,353
Cash and Cash Equivalents at End of Period	553,416	160,594	27,698
Supplemental disclosure of cash flow information
Interest	24,230	30,516	42,580
Income taxes, net of refunds		645	700
Noncash transactions:
Foreclosed loans transferred to other real estate owned	132,546	47,808	35,089
Loans to facilitate the sale of other real estate owned	1,148
Transfer of loans from held for investment to held for sale	31,832
Unrealized securities gains (losses), net of income taxes	810	(3,390)	3,235
Conversion of subordinated debt to preferred stock	5,000	7,500
Employee benefit plan costs, net of income taxes	(1,088)	558	(65)
Unrealized gains on interest rate swaps		249	51
Gain on repurchase and retirement of preferred stock	9,375
Conversion of Series A preferred stock to common stock	(8,982)
Exchange of unaccrued dividend on Series A preferred stock to common stock	4,334
Warrant agreement adjustment	3,891
Gain on conversion of Series A preferred stock to common stock	38,625
Assets acquired in business combination	724,452
Liabilities assumed in business combination	$ 723,433